PRESS RELEASE published on 10/11/2024 at 22:15, 6 months 20 days ago Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social Nanobiotix publie mensuellement le nombre total d'actions et de droits de vote. La société de biotechnologie développe des traitements innovants. Pour plus d'informations, visitez www.nanobiotix.com Droits De Vote Biotechnologie Actions Traitements NANOBIOTIX
PRESS RELEASE published on 10/11/2024 at 22:15, 6 months 20 days ago Voting Rights and Shares Capital of the Company Nanobiotix discloses voting rights and shares capital information. Find out more about the company's innovative therapeutic approaches Voting Rights Biotechnology Shares Capital NANOBIOTIX Therapeutic Approaches
PRESS RELEASE published on 09/18/2024 at 22:42, 7 months 12 days ago Rapport Financier Semestriel 2024
BRIEF published on 09/18/2024 at 22:20, 7 months 12 days ago NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers du premier semestre 2024 Augmentation Des Revenus Résultats Financiers De Nanobiotix Progression De NBTXR3 Étapes Cliniques Marquantes De L'argent Et De La Piste
BRIEF published on 09/18/2024 at 22:20, 7 months 12 days ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Revenue Increase Clinical Milestones Nanobiotix Financials NBTXR3 Progress Cash And Runway
PRESS RELEASE published on 09/18/2024 at 22:15, 7 months 12 days ago NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results Nanobiotix updates on operational progress and reports Half Year 2024 financial results, showcasing clinical milestones and licensing agreements with Janssen. Cash reserves extended until Q4 2025 Financial Results Clinical Milestones NANOBIOTIX Half Year 2024 Janssen Agreement
PRESS RELEASE published on 09/18/2024 at 22:15, 7 months 12 days ago NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2024 Nanobiotix publie ses résultats financiers et présente les avancées de NBTXR3, une approche innovante en oncologie basée sur les nanoparticules. Nouvelles collaborations et perspectives de développement clinique Résultats Financiers Oncologie NANOBIOTIX NBTXR3 Nanoparticules
BRIEF published on 09/04/2024 at 22:20, 7 months 26 days ago NANOBIOTIX renforce son Conseil de Surveillance avec deux ajouts clés Biotechnologie Conseil De Surveillance NANOBIOTIX Dr Liu Anat Nachitz
BRIEF published on 09/04/2024 at 22:20, 7 months 26 days ago NANOBIOTIX Enhances Supervisory Board with Two Key Additions Biotechnology Supervisory Board NANOBIOTIX Dr. Liu Anat Naschitz
PRESS RELEASE published on 09/04/2024 at 22:15, 7 months 26 days ago NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth Nanobiotix announces key additions to Supervisory Board - Dr. Margaret A. Liu & Ms. Anat Naschitz. Expertise to drive growth in nanophysics-based therapies for cancer & major diseases Supervisory Board NANOBIOTIX Dr. Margaret A. Liu Ms. Anat Naschitz Nanophysics-based Therapies
Published on 05/01/2025 at 08:00, 35 minutes ago Formation Metals Announces Appointment of Adrian Smith to Advisory Committee
Published on 05/01/2025 at 06:40, 1 hour 55 minutes ago Cerrado Gold Announces Q4 And Annual 2024 Financial Results
Published on 05/01/2025 at 05:25, 3 hours 10 minutes ago GLG Life Tech Corporation Reports 2024 Annual & Fourth Quarter Financial Results
Published on 05/01/2025 at 05:00, 3 hours 35 minutes ago Alphinat Announces a Profit of $51,824 for Fiscal Year Ended August 31, 2024
Published on 05/01/2025 at 04:25, 4 hours 10 minutes ago Alphinat Announces a Profit of $84,870 for Fiscal Year Ended August 31, 2023
Published on 05/01/2025 at 08:00, 34 minutes ago Ørsted divests 24.5% stake in West of Duddon Sands Offshore Wind Farm to funds managed by Schroders Greencoat
Published on 05/01/2025 at 08:00, 34 minutes ago Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares
Published on 04/30/2025 at 19:14, 13 hours 20 minutes ago Report de la publication des résultats annuels 2024
Published on 04/30/2025 at 19:14, 13 hours 20 minutes ago Solocal - Press Release - Filing of 2024 URD
Published on 04/30/2025 at 19:14, 13 hours 20 minutes ago Solocal - Communiqué de presse - Mise à disposition du DEU 2024
Published on 04/30/2025 at 18:55, 13 hours 39 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 5, 2025